Form 4: MKS Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
MKS Inc. Director Elizabeth Mora sold 300 shares of common stock for $158.81 per share, executed under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Elizabeth Mora, a Director at MKS Inc. (MKSI), reported a sale of common stock.
- The transaction involved the disposition of 300 shares.
- The shares were sold at a price of $158.81 per share.
- This sale was conducted on December 2, 2025.
- Following this transaction, Ms. Mora directly beneficially owns 18,963.394 shares of MKS Inc. common stock.
- The transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 19, 2025.
Sentiment
Score: 5
Explanation: A neutral score as this is a routine, pre-scheduled insider sale under a 10b5-1 plan, which typically has limited direct market impact beyond the factual reporting of a director's reduced holdings. It's not inherently positive or negative for the company's operational performance.
Positives
- The transaction was executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled sale rather than a reaction to immediate company news.
Negatives
- An insider sale, even if pre-planned, reduces the director's direct ownership in the company.
Future Outlook
NA
Industry Context
This is a routine insider transaction filing and does not provide specific industry context beyond the company's identity as MKS Inc. (MKSI), a technology company.
Related Party Transactions
- Elizabeth Mora, a Director of MKS Inc., sold 300 shares of common stock, which constitutes an insider transaction.
Stakeholder Impact
- Shareholders: The sale by a director slightly reduces insider ownership, which some investors might view as a minor negative, though mitigated by the 10b5-1 plan. The overall impact on the company's operations or strategic direction is negligible.
Key Dates
| Date | Description |
|---|---|
| 02/19/2025 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 12/02/2025 | Date of common stock transaction (sale). |
| 12/03/2025 | Date the Form 4 was signed by attorney-in-fact. |
Recommendation
holdThis Form 4 filing reports a routine, pre-scheduled insider sale by a director under a Rule 10b5-1 plan. Such transactions are typically not indicative of new material information about the company's performance or outlook. While it reduces insider ownership, the pre-planned nature suggests it's for personal financial management rather than a bearish signal. Therefore, it does not warrant a change in investment recommendation based solely on this filing.
Keywords
MKS Inc., MKSI, Insider Trading, Form 4, Stock Sale, Director, Elizabeth Mora, 10b5-1 Plan, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.